In the wake of the testimony given by Cheryl DeMars last year, Sen. Lamar Alexander is calling for ideas for legislation he will introduce to control health care costs. Health care costs are a growing burden on taxpayers, employers and family budget. Now is the time to share your ideas about ways to relieve that burden.
Ever since the U.S. Supreme Court upheld major portions of the Affordable Care Act (ACA) in 2012, health care providers, insurers and employers have been closely monitoring congressional and executive action to forecast the future of the law and its many provisions. The Dec. 14, 2018 ruling by a federal district court judge in Texas, Reed O’Connor, once again throws judicial action into the forefront of that mix.
Summary of testimony by Cheryl DeMars, President and CEO, The Alliance before the Senate Committee on Health, Education, Labor and Pensions Hearing on Nov. 28, 2018.
A recent Google search for “opioid crisis” produced 90 million results, an indication that America’s addiction to opioids has gained serious media attention over the last several years.
Two bills designed to promote transparency in the sale of prescription drugs by banning pharmacy “gag clauses” were passed by Congress and signed into law by the President this month.
American Patients First, the Trump Administration’s “blueprint to lower drug prices,” contains provisions with the potential for a significant impact on the health care marketplace, according to Alex Jung, managing director in the Parthenon-EY practice of Ernst & Young LLP.